AnaCardio AB: Clinical Trials

2 trials sponsored by AnaCardio AB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Not yet recruiting 1
Phase 11Completed 1

Follow AnaCardio AB: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure
AC01, Placebo - Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 2Not yet recruitingAnaCardio AB4002026-11-152026-09-14
Phase Ib/IIa Trial With AC01 in Patients With HFrEF
AC01, Placebo Minitablets - Heart Failure With Reduced Ejection Fraction
Phase 1 / Phase 2CompletedAnaCardio AB582023-02-232026-05-07

Conditions studied

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)

Countries

Italy (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Lars H Lund, MD PhD (1)

Results publications

PMID 42341796

NIH funding

2025 (1)